Skip to main content

Drug discovery and development in four Canadian biotech companies

Buy Article:

$51.00 plus tax (Refund Policy)


In this paper, we discuss the R&D process in the pharmaceutical/biotechnology industry from the viewpoint of four leading Canadian biotech startups. Based on a series of interviews with these firms, we outline the role of joint ventures and strategic alliances with university laboratories and with large established pharmaceutical firms in furthering these small firms’ ambition of themselves becoming large and established. We find that the evolution of this industry has made this goal much harder to reach and we discuss the creative ways in which these firms have adapted and thrived.

Document Type: Original Article


Affiliations: 1: Department of Economics, University of Guelph, Guelph, Ontario, Cananda, 2: Department of Management Sciences, University of Waterloo, Waterloo, Ontario, Canada, 3: Faculty of Management, University of Manitoba, Winnipeg, MB, Canada

Publication date: January 1, 2001


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more